http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478452-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf1b62cce4a4e8372fde38998774a4b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-88
filingDate 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57386e9436531190643355d5bf00dfcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f9330b583289b4bf8ccceb050deb7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1696612ecf10b799fdd092608b783ec7
publicationDate 2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114478452-A
titleOfInvention A kind of preparation method of mycophenolate sodium
abstract The invention belongs to the field of medicine, and in particular relates to a preparation method of mycophenolate sodium. The invention uses mycophenolic acid as a raw material to prepare an M2 crystal form mycophenolic sodium crude drug suitable for preparation. The preparation method of sodium mycophenolate provided by the invention uses mycophenolic acid of various purities as raw materials, can be purchased commercially, and the source of raw materials is easy to obtain; a solvent of methyl isobutyl ketone with low toxicity is used, which is easy to recover, The production cost is low, and at the same time, methyl isobutyl ketone is used as a crystallization solvent, and the crystallization conditions are mild, the obtained mycophenolate sodium is in the M2 crystal form, and the bulk density is in the range of 0.3-0.5 g/mL, which is convenient for the use of pharmaceutical preparations. The preparation method of mycophenolate sodium provided by the invention has a crystallization yield of over 93%, and the process is simple and convenient for industrial production.
priorityDate 2022-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448536187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454364176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411746874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454062057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18475210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395

Total number of triples: 36.